Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Accurate fungal identification is crucial for proper treatment in immunocompromised patients.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

A woman developed lupus after taking hydroxyurea for two years.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Tocilizumab might be an effective treatment for COVID-19.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

There might be a skin condition related to COVID-19.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

A cat had a rare severe reaction to fenbendazole, but recovered with treatment.

HLA can be linked to autoimmune hepatitis.

A post-COVID-19 patient in Manaus developed cryptococcal meningitis, highlighting the need for better health education and sanitation.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.